Chemler Joseph A, Yan Yajun, Leonard Effendi, Koffas Mattheos A G
State University of New York at Buffalo, Department of Chemical and Biological Engineering, 303 Furnas Hall, Buffalo, NY 14260, USA.
Org Lett. 2007 May 10;9(10):1855-8. doi: 10.1021/ol0703736. Epub 2007 Apr 21.
Flavonoids are plant secondary metabolites often used as nutraceutical supplements, but a growing number of unnatural flavonoids are being investigated as therapeutic agents. Cultures of Saccharomyces cerevisiae expressing recombinant flavonoid enzymes, including 4-coumaroyl:CoA ligase (4CL), chalcone synthase (CHS), chalcone isomerase (CHI), and flavanone 3beta-hydroxylase (FHT), produced novel flavanones and dihydroflavonols when fed with a number of aromatic acrylic acids. The flavonoid network also exhibited broad substrate specificity by converting muconic acid into a unique polypropanoid.
黄酮类化合物是植物次生代谢产物,常被用作营养补充剂,但越来越多的非天然黄酮类化合物正作为治疗剂进行研究。表达重组黄酮类酶(包括4-香豆酰辅酶A连接酶(4CL)、查尔酮合酶(CHS)、查尔酮异构酶(CHI)和黄烷酮3β-羟化酶(FHT))的酿酒酵母培养物,在加入多种芳香丙烯酸时会产生新的黄烷酮和二氢黄酮醇。黄酮类化合物网络还通过将粘康酸转化为独特的聚丙烷类化合物表现出广泛的底物特异性。